Abstract: Fibronectin Type III (FN3) polypeptide libraries are described, along with their use in identifying fibronectin-type binding peptides having high binding affinities, e.g., greater than 300 nM, for VEGFR2 or Axl proteins.
Type:
Grant
Filed:
May 22, 2013
Date of Patent:
June 28, 2016
Assignee:
Protelica, Inc.
Inventors:
Guido Cappuccilli, Roberto Crea, Randy Shen, Craig A. Hokanson, Peter B. Kirk, David R. Liston
Abstract: Fibronectin Type III (FN3) polypeptide libraries are described, along with their use in identifying fibronectin-type binding peptides having high binding affinities, e.g., greater than 300 nM, for VEGFR2 or Axl proteins.
Type:
Application
Filed:
May 22, 2013
Publication date:
May 15, 2014
Applicant:
PROTELICA, INC.
Inventors:
Guido Cappuccilli, Robert Crea, Randy Shen, Craig A. Hokanson, Peter B. Kirk, David R. Liston
Abstract: Walk-through mutagenesis and natural-variant combinatorial fibronectin Type III (FN3) polypeptide libraries are described, along with their method of construction and use. Also disclosed are a number of high binding affinity polypeptides selected by screening the libraries against a variety of selected antigens.
Type:
Grant
Filed:
August 4, 2010
Date of Patent:
April 15, 2014
Assignee:
Protelica, Inc.
Inventors:
Guido Cappuccilli, Roberto Crea, Randy Shen, Craig A. Hokanson, Peter B. Kirk, David R. Liston
Abstract: Walk-through mutagenesis and natural-variant combinatorial fibronectin Type III (FN3) polypeptide libraries are described, along with their method of construction and use. Also disclosed are a number of high binding affinity polypeptides selected by screening the libraries against a variety of selected antigens.
Type:
Grant
Filed:
September 18, 2009
Date of Patent:
March 25, 2014
Assignee:
Protelica, Inc.
Inventors:
Guido Cappuccilli, Roberto Crea, Randy Shen, Craig A. Hokanson, Peter B. Kirk, David R. Liston
Abstract: Fibronectin Type III (FN3) polypeptide libraries are described, along with their use in identifying fibronectin-type binding peptides having high binding affinities, e.g., greater than 300 nM, for VEGFR2 or Axl proteins.
Type:
Grant
Filed:
June 21, 2010
Date of Patent:
June 25, 2013
Assignee:
Protelica, Inc.
Inventors:
Guido Cappuccilli, Roberto Crea, Randy Shen, Craig A. Hokanson, Peter B. Kirk, David R. Liston